Scientists track hearing decline in adults with genetic mutation

NCT ID NCT06354010

Recruiting now Knowledge-focused Sponsor: Sensorion Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at adults aged 30 to 55 who have hearing loss that started after age 16 and carry a mutation in the GJB2 gene. Researchers will track how their hearing changes over time using hearing tests and genetic analysis. The goal is to better understand this form of hearing loss, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict how hearing loss progresses in people with GJB2 mutations, leading to earlier or more personalized care.
What could go wrong: This is an observational study, not a treatment trial. It will not test any drug or therapy, so it cannot directly improve hearing. Results may not apply to people without GJB2 mutations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SENSORINEURAL HEARING LOSS, BILATERAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Deafness Hearing Loss, Sensorineural presbycusis sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SENSORINEURAL HEARING LOSS, BILATERAL

Contacts and locations

Locations

CHU Gui de Chauliac
RECRUITING

Montpellier, 34295, France
The University of South Florida Board of Trustees
RECRUITING

Tampa, Florida, 33620, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.